John K. Buolamwini – författare
Visar alla böcker från författaren John K. Buolamwini. Handla med fri frakt och snabb leverans.
5 produkter
Novel Anticancer Agents
Strategies for Discovery and Clinical Testing
Av John K. Buolamwini, Alex A. Adjei
E-bok, 2011
2098 kr
Lägg i varukorg
Novel Anticancer Agents offers pertinent basic science information on strategies used for the rational design and discovery of novel anticancer agents, and, in addition, translational studies involving clinical trial design and execution with these novel, mostly cytostatic agents. This book covers …
Novel Anticancer Agents
Strategies for Discovery and Clinical Testing
Av Alex A. Adjei, John K. Buolamwini
Inbunden, 2005
1725 kr
Lägg i varukorg
Novel Anticancer Agents �offers pertinent basic science information on strategies used for the rational design and discovery of novel anticancer agents, and, in addition, translational studies involving clinical trial design and execution with these novel, mostly cytostatic agents. This book covers …
Novel Anticancer Drug Protocols
Av John K. Buolamwini, Alex A. Adjei
Inbunden, 2003
1685 kr
Lägg i varukorg
This book not only surveys the whole arena of novel anticancer drug targets, but also presents a wide-ranging selection of cutting-edge techniques currently being applied throughout novel antitumor drug discovery and development. The methods are applied to experiments involving such topics as …
Novel Anticancer Drug Protocols
Av John K. Buolamwini, Alex A. Adjei
Häftad, 2013
1685 kr
Lägg i varukorg
We are in an exciting era in the war against cancer, with real prospects for novel anticancer drugs that are cancer cell-specific without the toxicities that have been the hallmark of conventional cytotoxic cancer chemotherapy. Advances in cancer cell biology fueled by the molecular biology …
Novel Anticancer Drug Protocols
Av Alex A. Adjei, John K. Buolamwini
E-bok, 2008
2127 kr
Lägg i varukorg
We are in an exciting era in the war against cancer, with real prospects for novel anticancer drugs that are cancer cell-specific without the toxicities that have been the hallmark of conventional cytotoxic cancer chemotherapy. Advances in cancer cell biology fueled by the molecular biology …
